AAAAAA

   
Results: 1-11 |
Results: 11
The hemostatic effects of warfarin titration in post CABG patients in comparison to placebo treatment
Authors: Walenga, JM Hoppensteadt, D Pifarre, R Fox, NL Forman, S Hunninghake, DB Campeau, L Herd, JA Hoogwerf, BJ Hickey, A Probstfield, JL Terrin, ML
Citation: Jm. Walenga et al., The hemostatic effects of warfarin titration in post CABG patients in comparison to placebo treatment, J THROMB TH, 11(2), 2001, pp. 143-149
Frecuency and risk of asbestos-related lung cancer
Authors: Badorrey, MI Monso, E Teixido, A Pifarre, R Rosell, A Llatjos, M
Citation: Mi. Badorrey et al., Frecuency and risk of asbestos-related lung cancer, MED CLIN, 117(1), 2001, pp. 1-6
Frequency and risk of asbestos-related lung cancer
Authors: Badorrey, MI Monso, E Teixido, A Pifarre, R Rosell, A Llatjos, M
Citation: Mi. Badorrey et al., Frequency and risk of asbestos-related lung cancer, MED CLIN, 117(1), 2001, pp. 1-6
Left ventricular free wall rupture complicating acute myocardial infarction
Authors: Pifarre, R
Citation: R. Pifarre, Left ventricular free wall rupture complicating acute myocardial infarction, EVIDENCE-BASED MANAGEMENT OF THE ACUTE CORONARY SYNDROME, 2001, pp. 417-423
Repair of left ventricular aneurysm
Authors: Pifarre, R
Citation: R. Pifarre, Repair of left ventricular aneurysm, EVIDENCE-BASED MANAGEMENT OF THE ACUTE CORONARY SYNDROME, 2001, pp. 435-444
Inadequacy of current prevention strategies for heparin-induced thrombocytopenia (vol 5, pg S16, 1999)
Authors: Wallis, DE Lewis, BE Messmore, HL Pifarre, R Walenga, JM
Citation: De. Wallis et al., Inadequacy of current prevention strategies for heparin-induced thrombocytopenia (vol 5, pg S16, 1999), CL APPL T-H, 6(2), 2000, pp. 114-114
Mechanism of blood coagulation. Newer aspects of anticoagulant and antithrombotic therapy
Authors: Jeske, W Hoppensteadt, DA Pifarre, R Walenga, JM Fareed, J
Citation: W. Jeske et al., Mechanism of blood coagulation. Newer aspects of anticoagulant and antithrombotic therapy, ACUTE PULMONARY EMBOLISM, 2000, pp. 95-122
Inadequacy of current prevention strategies for heparin-induced thrombocytopenia
Authors: Wallis, DE Lewis, BE Messmore, HL Pifarre, R Walenga, JM
Citation: De. Wallis et al., Inadequacy of current prevention strategies for heparin-induced thrombocytopenia, CL APPL T-H, 5, 1999, pp. S16-S20
Hemostatic effects of 1 mg daily warfarin on post CABG patients
Authors: Walenga, JM Hoppensteadt, D Pifarre, R Cressman, MD Hunninghake, DB Fox, NL Terrin, ML Probstfield, JL
Citation: Jm. Walenga et al., Hemostatic effects of 1 mg daily warfarin on post CABG patients, J THROMB TH, 7(3), 1999, pp. 313-318
Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia
Authors: Wallis, DE Workman, DL Lewis, BE Steen, L Pifarre, R Moran, JF
Citation: De. Wallis et al., Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia, AM J MED, 106(6), 1999, pp. 629-635
TMR: Is it still a physiological impossibility?
Authors: Pifarre, R
Citation: R. Pifarre, TMR: Is it still a physiological impossibility?, DEV CARD M, 211, 1999, pp. 45-59
Risultati: 1-11 |